Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
UG

UG - United-Guardian Inc Stock Price, Fair Value and News

8.30USD+0.13 (+1.59%)Market Closed
Watchlist

Market Summary

USD8.30+0.13
Market Closed
1.59%

UG Stock Price

View Fullscreen

UG RSI Chart

UG Valuation

Market Cap

38.1M

Price/Earnings (Trailing)

15.11

Price/Sales (Trailing)

3.45

EV/EBITDA

9.48

Price/Free Cashflow

14.93

UG Price/Sales (Trailing)

UG Profitability

Operating Margin

51.99%

EBT Margin

28.66%

Return on Equity

23.69%

Return on Assets

20.73%

Free Cashflow Yield

6.7%

UG Fundamentals

UG Revenue

Revenue (TTM)

11.0M

Rev. Growth (Yr)

26.5%

Rev. Growth (Qtr)

15.37%

UG Earnings

Earnings (TTM)

2.5M

Earnings Growth (Yr)

81.4%

Earnings Growth (Qtr)

35.93%

Breaking Down UG Revenue

Last 7 days

-7.0%

Last 30 days

7.9%

Last 90 days

6.2%

Trailing 12 Months

-24.6%

How does UG drawdown profile look like?

UG Financial Health

Current Ratio

7.88

UG Investor Care

Dividend Yield

12.78%

Dividend/Share (TTM)

1.1

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202311.4M10.4M11.0M0
202214.4M14.4M13.6M12.7M
202111.1M11.8M12.6M13.9M
202011.9M11.6M11.3M11.0M
201913.1M12.5M12.4M12.1M
201814.2M14.2M14.3M13.6M
201711.7M13.4M13.1M13.4M
201612.0M10.1M10.0M11.1M
201513.9M15.0M16.1M14.0M
201415.4M14.8M13.9M13.4M
201313.9M13.8M13.7M15.4M
201214.6M14.3M14.4M13.8M
201113.9M14.0M14.2M14.3M
201000013.7M

Tracking the Latest Insider Buys and Sells of United-Guardian Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 19, 2021
globus kenneth h
gifted
-
-
-8,400
president
Mar 05, 2020
globus kenneth h
gifted
-
-
-8,000
president
May 20, 2019
globus kenneth h
gifted
-
-
-5,600
president

1–3 of 3

Which funds bought or sold UG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 14, 2024
GAMCO INVESTORS, INC. ET AL
added
0.97
-40,185
1,123,200
0.01%
Feb 14, 2024
Royal Bank of Canada
reduced
-24.07
-
1,000
-%
Feb 14, 2024
VANGUARD GROUP INC
added
1.48
-29,295
959,364
-%
Feb 14, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC
unchanged
-
-4,444
96,955
-%
Feb 14, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
new
-
76,385
76,385
-%
Feb 14, 2024
Ameritas Advisory Services, LLC
reduced
-31.54
-134,450
254,823
0.01%
Feb 14, 2024
BANK OF AMERICA CORP /DE/
unchanged
-
-1.00
7.00
-%
Feb 13, 2024
GEODE CAPITAL MANAGEMENT, LLC
unchanged
-
-8,033
175,143
-%

1–10 of 35

Are Funds Buying or Selling UG?

Are funds buying UG calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own UG
No. of Funds

Unveiling United-Guardian Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
renaissance technologies llc
4.13%
189,663
SC 13G/A
Feb 11, 2022
renaissance technologies llc
5.01%
230,263
SC 13G/A
Feb 11, 2021
renaissance technologies llc
5.84%
268,123
SC 13G/A
Feb 13, 2020
renaissance technologies llc
5.94%
272,800
SC 13G/A

Recent SEC filings of United-Guardian Inc

View All Filings
Date Filed Form Type Document
Feb 02, 2024
8-K
Current Report
Jan 10, 2024
3
Insider Trading
Jan 08, 2024
8-K
Current Report

What is the Fair Value of UG?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to United-Guardian Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
378.9B
83.9B
4.59% 13.92%
25.65
4.51
4.55% 3.44%
71.0B
19.5B
3.18% 13.50%
30.87
3.65
8.29% 28.85%
53.8B
15.2B
8.58% -41.51%
96.72
3.55
-7.33% -74.76%
24.5B
5.9B
0.13% 18.35%
32.39
4.17
3178.16% 82.56%
19.0B
7.3B
5.41% 0.36%
237.11
2.59
3.47% -81.61%
11.7B
6.0B
-2.78% 14.31%
36.16
1.95
14.07% 132.95%
MID-CAP
10.3B
890.1M
10.39% 143.94%
79.74
11.59
79.24% 176.22%
4.9B
1.3B
8.91% 33.38%
30.59
3.74
31.74% 54.03%
3.0B
8.1B
-9.66% -46.45%
-7.73
0.37
-14.02% -296.95%
3.0B
2.0B
0.53% 18.08%
18.42
1.49
-7.82% 10.32%
SMALL-CAP
2.0B
792.6M
17.04% 4.37%
-55.62
2.51
78.34% 58.46%
1.9B
2.3B
0.90% -12.74%
18.03
0.85
4.31% 6.67%
176.9M
193.7M
15.24% 103.88%
29.54
0.91
-1.01% 0.37%
59.6M
273.5M
-13.00% 286.67%
-1.28
0.22
-18.31% 63.14%
38.1M
11.0M
7.89% -24.64%
15.11
3.45
-18.80% -16.08%

United-Guardian Inc News

Latest updates
CNN23 Feb 202401:54 am
InvestorsObserver02 Feb 202408:00 am
Seeking Alpha18 months ago

United-Guardian Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue15.4%3,0582,6502,5702,7632,4173,6263,8923,6613,1803,6583,4312,3722,3362,9553,3233,3203,3173,2793,1802,6643,344
Costs and Expenses9.5%2,3362,1321,7392,1171,7292,4262,3892,3041,9102,1421,9061,8641,5831,8912,0122,1702,0362,0631,9341,8531,815
Operating Expenses-14.9%488574518475532620547607459513457506493512515555544502547545519
  R&D Expenses-23.8%98.0012912712612111213213013113088.0012011510910810010594.0099.0010898.00
EBITDA Margin5.3%0.30*0.28*0.28*0.26*0.29*0.33*0.39*0.43*0.43*0.42*-----------
Income Taxes34.4%16011919616589.00165239287267354311147188313208385284274325112350
Earnings Before Taxes35.6%7875809528444347991,1511,4031,2841,6991,4927589061,5009981,7751,3541,3531,5486951,666
EBT Margin6.0%0.29*0.27*0.27*0.25*0.28*0.32*0.38*0.42*0.41*0.41*-----------
Net Income35.9%6274617566793466339111,1161,0171,3451,1816117181,1877901,3901,0701,0791,2235831,317
Net Income Margin6.0%0.23*0.22*0.21*0.20*0.22*0.26*0.30*0.33*0.33*0.33*-----------
Free Cashflow153.0%1,0964334156106881,13023.001,6309881,617-----------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets2.5%12,17311,87711,94010,64011,67611,68112,94112,24213,62612,42613,32011,92012,84712,83013,29812,36313,53412,50313,97012,54514,141
  Current Assets2.2%11,61611,36311,2429,97110,87511,07912,31211,58312,96211,78412,65311,24712,14812,11312,54211,56712,70111,69813,14211,68713,244
    Cash Equivalents9.8%7,1166,4831,2028304973565125316927448625918852,2077901,0481,795911499550725
  Inventory-31.0%1,2281,7792,4701,6722,2951,7281,4981,4111,2879181,3331,4161,5451,5231,3631,2171,2741,3011,3251,4821,466
  Net PPE8.4%557514537559616603629659664642667674696710745781814783803828864
  Current Liabilities8.9%1,4741,3541,9181,3741,6641,9832,0102,3381,7071,4501,5711,4141,2182,0251,5721,3431,5291,5951,5581,3661,251
Shareholder's Equity1.6%10,65110,48410,0239,26710,0129,66610,7339,82111,69110,67511,53610,35411,39810,68011,42410,63311,76910,70012,14810,92512,869
  Retained Earnings1.7%10,19210,0249,5638,8079,5529,20710,2739,36211,23210,21511,0769,89510,93810,22110,96410,17311,31010,24011,68810,46612,409
Accumulated Depreciation0.4%7,0657,0407,0156,9916,9726,9386,9046,8706,8316,8306,7956,7606,7206,6846,6476,6106,5676,5266,4876,4496,404
Shares Outstanding0%4,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,594---------
Float------68,869---68,961---48,900---49,131---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations167.9%1,1654354186257361,13727.001,6651,0311,627990673-2611,8961,2878499841,1111,5321,0421,192
Cashflow From Investing-101.5%-72.054,846-46.091,133-594406-47.131,160-1,083460-719687-1,0601,450-1,545930-1001,825-1,5821,308-4,322
Cashflow From Financing-Infinity%-459---1,424----2,985----1,653----2,524----2,524-
  Dividend Payments-459--1,424---2,985---1,653---2,525---2,525-

UG Income Statement

2023-09-30
Statements of Income (Unaudited) - USD ($)
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net sales$ 3,057,518$ 2,417,022$ 8,278,141$ 9,935,557
Costs and expenses:    
Cost of sales1,749,0411,076,0354,272,0434,479,905
Operating expenses488,464532,3331,580,5031,699,311
Research and development98,141120,924353,829364,856
Total costs and expenses2,335,6461,729,2926,206,3756,544,072
Income from operations721,872687,7302,071,7663,391,485
Other Income:    
Investment income79,68246,995182,264146,405
Net (loss) gain on marketable securities(14,357)(300,526)65,823(1,154,464)
Total other income (expense)65,325(253,531)248,087(1,008,059)
Income before provision for income taxes787,197434,1992,319,8532,383,426
Provision for income taxes160,44188,681475,922493,119
Net income$ 626,756$ 345,518$ 1,843,931$ 1,890,307
Earnings per common share    
(Basic and Diluted) (in dollars per share)$ 0.14$ 0.07$ 0.40$ 0.41
Weighted average shares – basic and diluted (in shares)4,594,3194,594,3194,594,3194,594,319

UG Balance Sheet

2023-09-30
Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 7,116,131$ 830,452
Marketable securities928,8475,653,516
Accounts receivable, net of allowance for credit losses of $28,613 at September 30, 2023 and $20,063 at December 31, 20221,816,2421,427,576
Inventories, net1,228,0761,672,012
Prepaid expenses and other current assets132,699201,846
Prepaid income taxes393,636185,228
Total current assets11,615,6319,970,630
Deferred income taxes0110,544
Net property, plant, and equipment:  
Land69,00069,000
Factory equipment and fixtures4,615,3874,585,055
Building and improvements2,937,7462,895,742
Total property, plant, and equipment7,622,1337,549,797
Less: Accumulated depreciation7,064,9916,990,636
Total property, plant, and equipment, net557,142559,161
TOTAL ASSETS12,172,77310,640,335
Current liabilities:  
Accounts payable166,19930,415
Accrued expenses1,286,1661,322,056
Dividends payable21,26521,220
Total current liabilities1,473,6301,373,691
Deferred income taxes48,0000
Commitments and Contingencies 
Stockholders’ equity:  
Common stock (at $.10 par value) (10,000,000 shares authorized; 4,594,319 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively)459,432459,432
Retained earnings10,191,7118,807,212
Total stockholders’ equity10,651,1439,266,644
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$ 12,172,773$ 10,640,335
UG
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.
 WEBSITEwww.u-g.com
 EMPLOYEES23

United-Guardian Inc Frequently Asked Questions


What is the ticker symbol for United-Guardian Inc? What does UG stand for in stocks?

UG is the stock ticker symbol of United-Guardian Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of United-Guardian Inc (UG)?

As of Fri Feb 23 2024, market cap of United-Guardian Inc is 38.13 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of UG stock?

You can check UG's fair value in chart for subscribers.

What is the fair value of UG stock?

You can check UG's fair value in chart for subscribers. The fair value of United-Guardian Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of United-Guardian Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for UG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is United-Guardian Inc a good stock to buy?

The fair value guage provides a quick view whether UG is over valued or under valued. Whether United-Guardian Inc is cheap or expensive depends on the assumptions which impact United-Guardian Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for UG.

What is United-Guardian Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Feb 23 2024, UG's PE ratio (Price to Earnings) is 15.11 and Price to Sales (PS) ratio is 3.45. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. UG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on United-Guardian Inc's stock?

In the past 10 years, United-Guardian Inc has provided -0.069 (multiply by 100 for percentage) rate of return.